Remdesivir is the only antiviral drug that is approved by the Food and Drug Administration (FDA) for the treatment of COVID-19.

1. U.S. FDA grants full approval to Pfizer COVID vaccine for ages 12-15

  • Author: reuters.com
  • Updated: 2023-01-28
  • Rated: 88/100 ⭐ (3369 votes)
  • High rate: 88/100 ⭐
  • Low rate: 54/100 ⭐
  • Summary: U.S. FDA grants full approval to Pfizer COVID vaccine for ages 12
  • Matched Content: U.S. FDA grants full approval to Pfizer COVID vaccine for ages 12-15 July 8 (Reuters) - The U.S. Food and Drug Administration said on Friday 
  • Read more: here
  • Edited by: Mireielle Haily

2. FDA awards grants and contracts linked to rare diseases, including

  • Author: biopharma-reporter.com
  • Updated: 2023-01-19
  • Rated: 96/100 ⭐ (7535 votes)
  • High rate: 99/100 ⭐
  • Low rate: 55/100 ⭐
  • Summary: FDA awards grants and contracts linked to rare diseases, including
  • Matched Content: FDA awards grants and contracts linked to rare diseases, including ALS. The US Food and Drug Administration (FDA) has awarded 19 new grants and 
  • Read more: here
  • Edited by: Beverlie Drandell

3. FDA Awards Six Grants to Fund New Clinical Trials to Advance

  • Author: globalgenes.org
  • Updated: 2022-12-11
  • Rated: 76/100 ⭐ (1552 votes)
  • High rate: 78/100 ⭐
  • Low rate: 55/100 ⭐
  • Summary: FDA Awards Six Grants to Fund New Clinical Trials to Advance
  • Matched Content: FDA Awards Six Grants to Fund New Clinical Trials to Advance Development of Rare Disease Treatments The U.S. Food and Drug Administration 
  • Read more: here
  • Edited by: Julianne Garlan

4. The FDA Awards 12 Grants that Fund New Clinical Trials to Advance

  • Author: trialsitenews.com
  • Updated: 2022-10-15
  • Rated: 67/100 ⭐ (5666 votes)
  • High rate: 78/100 ⭐
  • Low rate: 46/100 ⭐
  • Summary: The FDA Awards 12 Grants that Fund New Clinical Trials to Advance
  • Matched Content: The U.S. Food and Drug Administration (FDA) has awarded 12 new clinical trial research grants amounting to over $15 million over the next 
  • Read more: here
  • Edited by: Roseann Colene